Search

Your search keyword '"Paolo Chiodini"' showing total 345 results

Search Constraints

Start Over You searched for: Author "Paolo Chiodini" Remove constraint Author: "Paolo Chiodini"
345 results on '"Paolo Chiodini"'

Search Results

1. Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial

2. Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review

3. Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

4. CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy

5. Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative

6. Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy

7. Chocolate Eaters Do Not Necessarily Win a Nobel Prize—Authors in Special Issues Do Not Necessarily Publish Lower Quality Papers

8. A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years

9. Reproductive and hormonal factors and risk of renal cell carcinoma among women in the European Prospective Investigation into Cancer and Nutrition

10. A Retrospective Study (2015–2020) on the Risk Factors Associated with the Persistence and Spread of Brucellosis in Buffalo Farms in Caserta Province, Italy

11. Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial

12. 41 CD39 affect the prognostic role of NLR via N2 neutrophils in metastatic melanoma patients treated with immunotherapy

13. 1247 Gene signature predict autoimmune toxicity in patients with metastatic melanoma

14. Easy Anthropometric Measurements Are Representative of Baseline Values of Breast Q Values in Asymptomatic Women

15. Hyperkalemia in CKD: an overview of available therapeutic strategies

16. The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

17. Risk Factors for the Spread of Brucellosis in Sheep and Goats in the Campania Region in the Years 2015–2020

18. The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs

19. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

20. Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression

21. GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs

22. Comparing the COVID-19 pandemic in space and over time in Europe, using numbers of deaths, crude rates and adjusted mortality trend ratios

23. Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease

24. Modeling for the Stringency of Lock-Down Policies: Effects of Macroeconomic and Healthcare Variables in Response to the COVID-19 Pandemic

25. A scoping review of retracted publications in anesthesiology

26. Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection

27. A Maximum-Entropy Fuzzy Clustering Approach for Cancer Detection When Data Are Uncertain

28. A new 'hub and spoke' teledermoscopy system involving general practitioners and dermatologists for the early detection of cutaneous melanoma: a pilot study

29. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

30. Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney

31. Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol

33. Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study

34. Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab

35. Unsupervised Hierarchical Classification Approach for Imprecise Data in the Breast Cancer Detection

36. Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol

37. Preventive skin analgesia with lidocaine patch for management of post‐thoracotomy pain: Results of a randomized, double blind, placebo controlled study

38. Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients

39. Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study.

40. A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan

41. Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study.

42. Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study

43. Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter 'real life' study

44. Dietary Methyl-Group Donor Intake and Breast Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

45. Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care

46. Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent Datasets

47. Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta‐Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials

48. Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis

49. Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease

50. Antimicrobial Lock Therapy in Clinical Practice: A Scoping Review Protocol

Catalog

Books, media, physical & digital resources